F8 gene mutation profile and ITT response in a cohort of Italian haemophilia A patients with inhibitors

Haemophilia

Volumn 13, Issue 4, 2007, Pages 361-372

  Salviato, R ^a   Belvini, D ^a   Radossi, P ^a   Sartori, R ^a   Pierobon, F ^a   Zanotto, D ^a   Zanon, E ^b   Castaman, G ^c   Gandini, G ^d   Tagariello, Giuseppe ^a  

^a Dipartimento di Laboratorio   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

^d Centro Emofilia Ospedale Policlinico Verona   (Italy)

Author keywords

F8 gene; Haemophilia A; Inhibitors

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA SEQUENCE; DRUG MEGADOSE; DRUG RESPONSE; DRUG TREATMENT FAILURE; GEL ELECTROPHORESIS; GENE DELETION; GENE INSERTION; GENE MUTATION; HEMOPHILIA A; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INTRON; ITALY; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PHARMACOGENETICS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS;

BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION TESTS; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FACTOR VIII; HEMOPHILIA A; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; ITALY; MALE; MUTATION; PEDIGREE;

EID: 34447288973     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01437.x     Document Type: Article

References (46)

1. Kazazian HH Jr, Tuddenham EGD, Antonarakis SE. Hemophilia A and parahemophilia: Deficiencies of coagulation factors VIII and V. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Diseases. Seventh Edition. NY: McGraw Hill, Chapter 106, 1995: 3241-67.
2. Peake IR, Lillicrap DP, Boulyjenkov V et al. Report of a joint WHO/WFH meeting on the control of haemophilia: Carrier detection and prenatal diagnosis. Blood Coagul Fibrinolysis 1993; 4: 313-44.
3. Lakich D, Kazazian HIR, Antonarakis SE. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet 1993; 5: 236-42.
4. Naylor JA, Brinke A, Hassock S. Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions. Hum Mol Genet 1993; 2: 1773-8.
5. Bagnall D, Waseem N, Green PM, Giannelli F. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe haemophilia A. Blood 2002; 99: 168-74.
6. Addiego J, Kasper CK, Abildgaard C et al. Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII. Lancet 1993; 342: 462-4.
7. Schwaab R, Brackmann HH, Meyer C et al. Haemophilia A: Mutation type determines risk of inhibitor formation. Thromb Haemost 1995; 74: 1402-6.
8. Hay CRM. Factor VIII inhibitors in mild and moderate-severity haemophilia A. Haemophilia 1998; 4: 558-63.
9. Lusher JM. Natural history of inhibitors in severe haemophilia A and B: incidence and prevalence. In: E.C. Rodriguez-Merchan and C.A. Lee, eds. 'Inhibitors in patients with haemophilia'. Great Britain: Blackwell Science, 2002: 38.
10. Brown DL, Bray GL, Scharrer I. Transient inhibitors in patients with hemophilia A. Thromb Haemost 1999; 82 (August suppl.): 573, abstract 1804.
11. Mariani G, Kroner B for the Immune Tolerance Study Group (ITSG). Immune tolerance in hemophilia with factor VIII inhibitors: Predictors of success. Haematologica 2001; 86: 1186-93.
12. Lorenzo JIL, Lopez A, Altisent C, Aznar JA. Incidence of factor FVIII inhibitors in severe haemophilia: The importance of patient age. Br J Haematol 2001; 113: 600-3.
13. Van der Bom JG, Mauser-Bunschoten EP, Fischer K, van der Berg HM. Age at first treatment and immune tolerance to factor VIII in severe hemophilia. Throm Haemost 2003; 89: 475-9.
14. Goodeve AC, Preston FE, Peake IR. Factor VIII gene rearrangement in patients with severe haemophilia A. Lancet 1994; 343: 329-30.
15. Kasper CK, Aledort LM, Counts RB et al. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 34: 869-72.
16. Liu Q, Nopzari G, Sommer SS. Single-tube polymerase chain reaction for rapid diagnosis of the inversion hotspot of mutation in haemophilia A. Blood 1998; 92: 1458-9.
17. Tagariello G, Belvini D, Salviato R et al. Experience of a single Italian center in genetic counseling for hemophilia: From linkage analysis to molecular diagnosis. Haematologica 2000; 85: 525-9.
18. Williams IJ, Abuzenadah A, Winship PR et al. Precise carrier diagnosis in families with haemophilia A: Use of conformation sensitive ge1 electrophoresis for mutation screening and polymorphism analysis. Thromb Haemost 1998; 79: 723-6.
19. Ganguly A, Rock MJ, Prockop DJ. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 1993; 90: 10325-9.
20. Salviato R, Belvini D, Are A, Radossi P, Tagariello G. Large FVIII gene deletion confers very high risk of inhibitor development in three related severe haemophiliacs. Haemophilia 2002; 8: 17-21.
21. Lombardi AM, Cabrio L, Zanon E et al. A large deletion due to a new mutation (intron 13/exon 23) in a sporadic case of severe hemophilia A. Clin Appl Thromb Hemost 2004; 10: 61-4.
22. Naylor JA, Green PM, Rizza CR, Giannelli F. Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia patients. Hum Mol Genet 1993; 2: 11-7.
23. Tizzano EF, Altisent C, Tusell J, Domenech M, Baiget M. Intron 22 inversions and haemophilia. Lancet 1994; 343: 792.
24. Ljung R, Sjorin E. Inversions of the factor VIII gene in Swedish patients with severe haemophilia A. Eur J Haematol 1995; 54: 310-3.
25. Poon MC, Low S, Sinclair GD. Factor VIII gene rearrangement analysis and carrier determination in hemophilia A. J Lab Clin Med 1995; 125: 402-6.
26. Antonarakis SE, Rossiter JP, Young M et al. Factor VIII gene inversions in severe hemophilia A: Results of an international consortium study. Blood 1995; 86: 2206-12.
27. Weinmann AF, Schoof JM, Thompson AR. Clinical correlates among 49 families with hemophilia A and factor VIII gene inversions. Am J Hematol 1996; 51: 192-9.
28. Riccardi F, Tagliaferri A, Manotti C, Pattacini C, Neri TM. Intron factor VIII gene inversion in a population of Italian hemophilia A patients. Blood 2002; 100: 3432.
29. Tizzano EF, Cornet M, Baiget M. Inversion of intron 1 of the factor VIII gene for direct molecular diagnosis of hemophilia A. Haematologica 2003; 88: 118-20.
30. Acquila M, Pasino M, Lanza T, Bottini F, Boeri E, Bicocchi MP. Frequency of factor VIII 1 inversion in a cohort of severe hemophilia A Italian patients. Haematologica 2003; 88: ELT17.
31. Habart D, Kalabova D, Hrachovinova I, Vorlova Z. Significant prevalence of the intron 1 factor VIII gene inversion among patients with severe hemophilia A in the Czech Republic. J Thromb Haemost 2003; 1: 1323-4.
32. Ahmed R, Kannan M, Prakash Choudhry V, Saxena R. Mutation reports: intron 1 and 22 inversions in Indian haemophilics. Ann Hematol 2003; 82: 546-7.
33. Salviato R, Belvini D, Are A, Radossi P, Tagariello G. Factor VIII gene intron 1 inversion: Lower than expected prevalence in Italian haemophiliac severe patients. Haemophilia 2004; 10: 194-6.
34. Oldenburg J, Brackmann HH, Schwaab R. Risk factors for inhibitor development in hemophilia A. Haematologica 2000; 85: 7-14.
35. Knobe KE, Villoutreix BO, Tengborn LI, Petrini P, Ljung RCR. Factor VIII inhibitors in two families with mild haemophilia A: Structural analysis of the mutations. Haemostasis 2000; 30: 268-79.
36. Peerlinck K, Jacquemin MG, Arnout J et al. Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A. Blood 1999; 93: 2267-73.
37. Jacquemin M, Benhida A, Peerlinck M et al. A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor. Blood 2000; 95: 156-63.
38. Young M, Inaba H, Hoyer LW, Higuchi M, Kazazian HH, Antonarakis SE. Partial correction of a severe molecular defect in hemophilia A because of errors during expression of the factor VIII gene. Am J Hum Genet 1997; 60: 565-73.
39. Oldenburg J, Schoder J, Schmitt C, Brackmann HH, Schwaab R. Small deletion/insertion mutations within Poly-A runs of the factor VIII gene mitigate the severe haemophilia A phenotype. Thromb Haemost 1998; 79: 452-3.
40. Nakaya S, Liu ML, Thompson AR. Some factor VIII exon 14 frameshift mutations cause moderately severe haemophilia A. Br J Haematol 2001; 115: 977-82.
41. Thermann R, Neu-Yilik G, Deters A et al. Binary specification of non-sense codons by splicing and cytoplasmic translation. EMBO J 1998; 17: 3484-94.
42. Byers PH. Killing the messenger: New insights into non-sense-mediated mRNA decay. J Clin Invest 2002; 109: 3-6.
43. David D, Santos IMA, Johnson K, Tuddenham EGD, McVey JH. Analysis of the consequences of premature termination codons within factor VIII coding sequences. J Thromb Haemost 2003; 1: 139-46.
44. Peyvandi F, Jayandharan G, Chandy M et al. Genetic diagnosis of haemophilia and other inherited bleeding disorders. Haemophilia 2006; 12 (Suppl. 3): 82-9.
45. Antonarakis SE and the Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Hum Mutat 1998; 11: 1-3.
46. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat 2000; 15: 7-12.